Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.

The American cosmetics giant said demand for core fragrances from Chloé and Hugo Boss had insulated it from a further decline, and expects a return to growth in the second half of its fiscal year.

The American cosmetics giant said demand for core fragrances from Chloé and Hugo Boss had insulated it from a further decline, and expects a return to growth in the second half of its fiscal year.

The Ozempic and Wegovy maker pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs, underscoring the urgency facing its new chief executive.

The Ozempic and Wegovy maker pared its forecast for a fourth time this year on lagging sales of its blockbuster drugs, underscoring the urgency facing its new chief executive.

The future of big-name brands like Neutrogena, Clean & Clear and Aveeno, which bring more than $4 billion a year in sales, is less clear under its new ownership by the tissue and feminine care giant Kimberly-Clark.

The future of big-name brands like Neutrogena, Clean & Clear and Aveeno, which bring more than $4 billion a year in sales, is less clear under its new ownership by the tissue and feminine care giant Kimberly-Clark.

Kimberly-Clark Corp. agreed to buy Kenvue Inc. in a cash and stock deal that values the consumer-health company that owns brands like Tylenol at about $40 billion.

Kimberly-Clark Corp. agreed to buy Kenvue Inc. in a cash and stock deal that values the consumer-health company that owns brands like Tylenol at about $40 billion.

The Danish pharmaceutical company, which makes Ozempic and Wegovy, made a surprise offer for the US firm after Pfizer acquired it for $4.9 billion in September.

The Danish pharmaceutical company, which makes Ozempic and Wegovy, made a surprise offer for the US firm after Pfizer acquired it for $4.9 billion in September.
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Exports in August were buoyed by China and Japan, despite a sharp decline in shipments to the US.
The LVMH executive joins Nike’s board as the sportswear giant prepares to be removed from the S&P 100 index after nearly two decades.
The Fashion Awards ceremony, set for Nov. 30, will also recognise the BFC’s second Vanguard award recipient, recognising emerging British design talent.
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
LuxExperience posted a rise in sales as the luxury multibrand platform’s strategy of catering to the ultra wealthy helped it navigate a difficult environment for high-end fashion.
The global collective has brought film studio Smuggler under its umbrella to bolster its entertainment capabilities.